CA2292628A1 - Forme galenique solide a liberation immediate independante du ph de (+)- ou (-)-cisapride - Google Patents

Forme galenique solide a liberation immediate independante du ph de (+)- ou (-)-cisapride Download PDF

Info

Publication number
CA2292628A1
CA2292628A1 CA002292628A CA2292628A CA2292628A1 CA 2292628 A1 CA2292628 A1 CA 2292628A1 CA 002292628 A CA002292628 A CA 002292628A CA 2292628 A CA2292628 A CA 2292628A CA 2292628 A1 CA2292628 A1 CA 2292628A1
Authority
CA
Canada
Prior art keywords
cisapride
dosage form
tablet
solid dosage
tartrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002292628A
Other languages
English (en)
Inventor
Paul Marie Victor Gilis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica, N.V.
Paul Marie Victor Gilis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica, N.V., Paul Marie Victor Gilis filed Critical Janssen Pharmaceutica, N.V.
Publication of CA2292628A1 publication Critical patent/CA2292628A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002292628A 1997-06-11 1998-06-04 Forme galenique solide a liberation immediate independante du ph de (+)- ou (-)-cisapride Abandoned CA2292628A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP97201768 1997-06-11
EP97201767.7 1997-06-11
EP97201768.5 1997-06-11
EP97201767 1997-06-11
PCT/EP1998/003495 WO1998056364A1 (fr) 1997-06-11 1998-06-04 Forme galenique solide a liberation immediate independante du ph de (+)- ou (-)-cisapride

Publications (1)

Publication Number Publication Date
CA2292628A1 true CA2292628A1 (fr) 1998-12-17

Family

ID=26146581

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002292628A Abandoned CA2292628A1 (fr) 1997-06-11 1998-06-04 Forme galenique solide a liberation immediate independante du ph de (+)- ou (-)-cisapride

Country Status (6)

Country Link
EP (1) EP0988032A1 (fr)
JP (1) JP2002504107A (fr)
KR (1) KR20010012104A (fr)
AU (1) AU7919398A (fr)
CA (1) CA2292628A1 (fr)
WO (1) WO1998056364A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2443632C (fr) * 2001-04-10 2011-05-03 Sun Pharmaceutical Industries Limited Composition a liberation par impulsion reglee dans le temps
AU2005249367A1 (en) * 2004-04-16 2005-12-15 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and prokinetic agent
WO2013049731A1 (fr) * 2011-09-30 2013-04-04 Stomavite Llc Complément pour patient ayant subi une stomie

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2139636A1 (fr) * 1992-07-07 1994-01-20 Nancy M. Gray Methodes d'utilisation de la (+) cisapride pour le traitement du reflux gastro-oesophagien et d'autres troubles
WO1994001112A1 (fr) * 1992-07-07 1994-01-20 Sepracor Inc. Procedes d'utilisation de cisapride (-) pour le traitement du reflux gastro-×sophagien et d'autres troubles
EP0707492A1 (fr) * 1993-07-06 1996-04-24 Merck & Co. Inc. Combinaisons d'agents anti-h 2? et d'agents de motilite gastro-intestinale
ES2136157T3 (es) * 1994-03-01 1999-11-16 Gerhard Gergely Producto granular o comprimido que contiene un sistema efervescente y una sustancia farmaceutica activa, asi como un procedimiento para su preparacion.
CH686865A5 (de) * 1994-06-15 1996-07-31 Gergely Gerhard Pharmazeutische Zubereitung mit einem hydrophoben Wirkstoff und einem Brausesystem, sowie Verfahren zur Herstellung der Zubereitung.
ZA959221B (en) * 1994-11-02 1997-04-30 Janssen Pharmaceutica Nv Cisapride extended release
EP0803251B1 (fr) * 1996-04-23 2002-07-17 Janssen Pharmaceutica N.V. Formes solides d'administration de cisapride à libération immédiate et indépendente du PH

Also Published As

Publication number Publication date
WO1998056364A1 (fr) 1998-12-17
JP2002504107A (ja) 2002-02-05
KR20010012104A (ko) 2001-02-15
AU7919398A (en) 1998-12-30
EP0988032A1 (fr) 2000-03-29

Similar Documents

Publication Publication Date Title
US6030988A (en) Immediate release pH-independent solid dosage form of cisapride
JP4573397B2 (ja) 速崩壊性固形製剤
JP5002044B2 (ja) 錠剤の製造方法
EP0922464B1 (fr) Materiaux moules par compression, a desagregation rapide, et leur procede de production
AU2002320385B2 (en) Sequential drug delivery systems
US9492541B2 (en) Phenylepherine containing dosage form
CN107028900A (zh) 快速分散颗粒、口腔崩解片以及方法
JP2009114113A (ja) 口腔内崩壊錠及びその製造方法
WO2019130749A1 (fr) Nouveau revêtement de microparticules (particules creuses comprenant un médicament et procédé de fabrication de celles-ci)
TWI240638B (en) A film-coated solid-dosage form pharmaceutical composition
KR100846945B1 (ko) 파라세타몰을 포함하는 연하 정제
CN107530335A (zh) 新型药学用途
JP5138856B2 (ja) 錠剤の製造方法
EP0803251B1 (fr) Formes solides d'administration de cisapride à libération immédiate et indépendente du PH
WO2010087358A1 (fr) Nouvelle composition
CA2292628A1 (fr) Forme galenique solide a liberation immediate independante du ph de (+)- ou (-)-cisapride
US9364451B1 (en) Alternating sympathomimetic therapy for the treatment of respiratory ailments
JP2021138689A (ja) 錠剤、その製造方法、および医薬品
MXPA98008710A (en) Dosage form solid independent of the ph, of immediate release
US20210346303A1 (en) Coating method
WO2014027974A1 (fr) Formulation de palipéridone à désintégration orale
Konde Formulation and Evaluation of Orodispersible Tablets of Lansoprazole

Legal Events

Date Code Title Description
FZDE Dead